Mackenzie Financial Corp Cuts Stock Position in Maximus, Inc. $MMS

Key Points

• Mackenzie Financial trimmed its position in Maximus by 10.1% in Q3, selling 253,339 shares to leave 2,249,086 shares (about 3.99% of the company) valued at roughly $205.5 million, while institutional investors own 97.21% of the stock.
• Insiders increased their holdings — CFO David Mutryn bought 1,000 shares at $75.62 and CEO Bruce Caswell bought 3,175 shares at $78.45 — bringing insider ownership to 1.80%.
• Maximus slightly beat EPS expectations ($1.85 vs. $1.84) but revenue fell 4.1%; the company set FY2026 guidance of $8.05–$8.35 EPS, yet the stock is down about 4.9% and trading below its 50‑ and 200‑day moving averages (~$85).

Mackenzie Financial Corp trimmed its position in Maximus, Inc. (NYSE:MMS - Free Report) by 10.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,249,086 shares of the health services provider's stock after selling 253,339 shares during the period. Mackenzie Financial Corp owned approximately 3.99% of Maximus worth $205,499,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in MMS. Richardson Financial Services Inc. boosted its holdings in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 192 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in Maximus during the second quarter worth about $35,000. Cullen Frost Bankers Inc. acquired a new stake in Maximus during the third quarter worth about $38,000. Parkside Financial Bank & Trust raised its position in Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider's stock valued at $62,000 after acquiring an additional 157 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider's stock valued at $122,000 after acquiring an additional 163 shares during the period. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on MMS. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Monday, February 23rd. Weiss Ratings downgraded Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research report on Tuesday, February 24th. Finally, Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, Maximus presently has a consensus rating of "Buy".

Insider Buying and Selling at Maximus

In related news, CFO David Mutryn acquired 1,000 shares of the business's stock in a transaction on Monday, February 9th. The shares were bought at an average price of $75.62 per share, with a total value of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Bruce Caswell bought 3,175 shares of the firm's stock in a transaction that occurred on Tuesday, February 10th. The stock was purchased at an average cost of $78.45 per share, with a total value of $249,078.75. Following the completion of the transaction, the chief executive officer owned 328,013 shares in the company, valued at approximately $25,732,619.85. This trade represents a 0.98% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 1.80% of the company's stock.

Maximus Stock Down 4.9%

NYSE MMS opened at $73.49 on Wednesday. The business's fifty day simple moving average is $85.31 and its 200-day simple moving average is $85.96. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The firm has a market cap of $4.01 billion, a PE ratio of 11.19 and a beta of 0.59. Maximus, Inc. has a 52 week low of $64.68 and a 52 week high of $100.00.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.01. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. Maximus's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a dividend of $0.33 per share. This is a boost from Maximus's previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus's dividend payout ratio (DPR) is presently 20.09%.

About Maximus

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.